- Home
- GPN vs PODD Comparison
GPN vs PODD Comparison
Compare GPN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPN
- PODD
- Stock Information
- Founded
- GPN 1967
- PODD 2000
- Country
- GPN United States
- PODD United States
- Employees
- GPN N/A
- PODD N/A
- Industry
- GPN Business Services
- PODD Medical/Dental Instruments
- Sector
- GPN Consumer Discretionary
- PODD Health Care
- Exchange
- GPN Nasdaq
- PODD Nasdaq
- Market Cap
- GPN 20.3B
- PODD 21.5B
- IPO Year
- GPN 2001
- PODD 2007
- Fundamental
- Price
- GPN $86.79
- PODD $321.27
- Analyst Decision
- GPN Buy
- PODD Strong Buy
- Analyst Count
- GPN 29
- PODD 19
- Target Price
- GPN $114.92
- PODD $324.68
- AVG Volume (30 Days)
- GPN 2.6M
- PODD 708.9K
- Earning Date
- GPN 08-06-2025
- PODD 08-07-2025
- Dividend Yield
- GPN 1.15%
- PODD N/A
- EPS Growth
- GPN 4.93
- PODD N/A
- EPS
- GPN 5.73
- PODD 3.32
- Revenue
- GPN $10,066,209,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- GPN N/A
- PODD $24.54
- Revenue Next Year
- GPN $6.35
- PODD $17.48
- P/E Ratio
- GPN $14.70
- PODD $96.68
- Revenue Growth
- GPN 15.51
- PODD 26.00
- 52 Week Low
- GPN $65.93
- PODD $180.31
- 52 Week High
- GPN $120.00
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- GPN 60.22
- PODD 67.49
- Support Level
- GPN $80.59
- PODD $302.41
- Resistance Level
- GPN $87.86
- PODD $322.80
- Average True Range (ATR)
- GPN 2.82
- PODD 9.29
- MACD
- GPN 0.52
- PODD 3.87
- Stochastic Oscillator
- GPN 82.11
- PODD 96.70
About GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.